ArticleMolecules (Basel, Switzerland)2026
In Vitro Antioxidant and Cellular Activities of Functionalized Spermidine by Conjugating with Ascorbic Acid in Human Skin Cells.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Spermidine (SPMD) is essential for numerous cellular functions and crucial for sustaining diverse biological activities. However, its antioxidant capabilities are relatively weak. In this study, we overcame this limitation by examining the antioxidant and cellular effects of ascorbic acid (AA)-conjugated spermidine (AA-SPMD) in human skin keratinocyte and fibroblast cells. AA-SPMD was successfully fabricated using an optimized design and synthetic approach, and its stability, antioxidant activity, cellular responses, and collagen I production were evaluated. In addition, we assessed the protective effects of AA-SPMD from hydrogen peroxide and UVA-induced oxidative damage in human skin cells. The AA-SPMD showed high stability under rigorous conditions and exhibited strong antioxidant activity. AA-SPMD showed no cytotoxic effect even at a concentration of 1 mM. In addition, it can increase the rate of cell proliferation and migration in skin cells without reducing the inhibition of human keratinocytes (HaCaT) and human dermal fibroblasts (HDF) at concentrations of 10 μM. Moreover, AA-SPMD can increase the amount of collagen I synthesized in HDF cells, thereby influencing cell proliferation and migration. Based on our in vitro study, AA-SPMD is expected to be more effective than AA or SPMD alone, indicating its potential utility in biomedical and cosmetic applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.